Modern approaches to the treatment of vulvovaginal candidiasis


Cite item

Full Text

Abstract

The review presents the current data on the approach to the management of vulvovaginal candidosis (VVC). It is shown that the main current trend in the management of acute VVC is the use of short courses of antifungal therapy with a local application of azole. Fenticonazole is currently the drug of choice in the treatment of VVC has a high efficiency and safety.

About the authors

N V Artymuk

Kemerovo State Medical Academy of the Ministry of Health of the Russian Federation

Email: artymuk@gmail.com
д-р мед. наук, проф., зав. каф. акушерства и гинекологии №2 ГБОУ ВПО КемГМА 650029, Russian Federation, Kemerovo, ul. Voroshilova, d. 22a

V I Chernyaeva

Kemerovo State Medical Academy of the Ministry of Health of the Russian Federation

канд. мед. наук, доц. каф. акушерства и гинекологии №2 ГБОУ ВПО КемГМА 650029, Russian Federation, Kemerovo, ul. Voroshilova, d. 22a

References

  1. Holland J, Young M.L, Lee O, Chen S. Vulvovaginal carriage of yeasts other than Candida albicans. Sexually transmitted infections 2003; 79 (3): 249-50.
  2. Sobel J.D. Pathogenesis and epidemiology of vulvovaginal candidiasis. [Review]; [60 refs]. Ann NY Acad Sci 1988; 544: 547-57
  3. Van Schalkwyk J, Yudin M.H, Infectious Disease Committee et al. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. J Obstet Gynaecol Can 2015; 37 (3): 266-74.
  4. European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge 2011.
  5. United Kingdom National Guideline on the Management of Vulvovaginal Candidiasis 2007.
  6. STD Treatment Guidelines 2010.
  7. Ferris D.G, Dekle C, Litaker M.S. Women's use of over - the - counter antifungal medications for gynecologic symptoms. J Fam Pract 1996; 42 (6): 595-600.
  8. Кира Е.Ф., Беженарь В.Ф., Савичева А.М. Эффективность и безопасность сертаконазола (залаин) и натамицина (пимафуцин) в лечении острого урогенитального кандидоза у женщин. Акушерство и гинекология. 2007; 6: 50. / Kira E.F., Bezhenar' V.F., Savicheva A.M. Effektivnost' i bezopasnost' sertakonazola (zalain) i natamitsina (pimafutsin) v lechenii ostrogo urogenital'nogo kandidoza u zhenshchin. Akusherstvo i ginekologiia. 2007; 6: 50. [in Russian]
  9. Савичева А.М. Лечение острого кандидозного вульвовагинита: современные тенденции. Акушерство и гинекология. 2010; 5: 59-62.
  10. British Association of Sexual Health and HIV Clinical Effectiveness Group guidelines ‘Sexually Transmitted Infections: UK National Screening and Testing Guidelines’, August 2006 for comprehensive guidance. www.bashh.org/guidelines/2006/sti_screening_guidelines_v14_0806. Pdf
  11. Mikamo H, Matsumizu M, Nakazuru Y et al. Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis in Japan. J Infect Chemother 2015; pii: S1341-321X(15)00076-8. doi: 10.1016/j.jiac.2015.03.011.
  12. Li T, Zhu Y, Fan S et al. A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis. Med Mycol 2015; pii: myv017.
  13. Veronese M, Salvaterra M, Barzaghi D. Fenticonazole, a new imidazole derivative with antibacterial and antifungal activity. In vitro study. Arzneimittelforschung 1981; 31 (12): 2133-7.
  14. Palacín C, Tarragó C, Agut J, Guglietta A. In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates. Methods Find Exp Clin Pharmacol 2001; 23 (2): 61-4.
  15. Hernández Molina J.M, Llosá J et al. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp. Mycopathologia 1992; 118 (1): 15-21.
  16. Van Cutsem J. The in vitro activity of terconazole against yeasts: its topical long - acting therapeutic efficacy in experimental vaginal candidiasis in rats. Am J Obstet Gynecol 1991; 165 (4 Pt. 2): 1200-6.
  17. Feng Z, Zou Q, Tan X et al. Determination of fenticonazole enantiomers by LC-ESI-MS/MS and its application to pharmacokinetic studies in female rats. Arzneimittelforschung 2011; 61 (10): 587-93.
  18. Van Cutsem J. The in vitro activity of terconazole against yeasts: its topical long - acting therapeutic efficacy in experimental vaginal candidiasis in rats. Am J Obstet Gynecol 1991; 165 (4 Pt. 2): 1200-6.
  19. Feng Z, Zou Q, Tan X et al. Determination of fenticonazole enantiomers by LC-ESI-MS/MS and its application to pharmacokinetic studies in female rats. Arzneimittelforschung 2011; 61 (10): 587-93.
  20. Van Cutsem J. The in vitro activity of terconazole against yeasts: its topical long - acting therapeutic efficacy in experimental vaginal candidiasis in rats. Am J Obstet Gynecol 1991; 165 (4 Pt. 2): 1200-6.
  21. Kovachev S, Nacheva A, Vacheva-Dobrevska R, Vasilev N. Combined single - day treatment in acute vulvovaginal candidosis. AkushGinekol (Sofiia) 2009; 48 (6): 18-23.
  22. Muzny C.A, Schwebke J.R. Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections. Clin Infect Dis 2015; pii: civ353. [Epub ahead of print]
  23. Sobel J.D. Vaginal Biofilm: Much Ado About Nothing, or a New Therapeutic Challenge? Clin Infect Dis 2015; pii: civ358. [Epub ahead of print]
  24. Lawrence A.G, Houang E.T, Hiscock E et al. Single dose therapy of vaginal candidiasis: a comparative trial of fenticonazole vaginal ovules versus clotrimazole vaginal tablets. Curr Med Res Opin 1990; 12 (2): 114-20.
  25. Studd J.W, Dooley M.M, Welch C.C et al. Comparative clinical trial of fenticonazole ovule (600 mg) versus clotrimazole vaginal tablet (500 mg) in the treatment of symptomatic vaginal candidiasis. Curr Med Res Opin 1989; 11 (8): 477-84.
  26. Muñoz Reyes J.R, Villanueva Reynoso C, Ramos C.J et al. Efficacy and tolerance of 200 mg fenticonazole versus 400 mg of miconazole in the intravaginal treatment of mycotic vulvovaginitis. Ginecol Obstet Mex 2002; 70: 59-65.
  27. Fernández-Alba J, Valle-Gay A, Dibildox M et al. 2004. Fenticonazole nitrate for treatment of vulvovaginitis: efficacy, safety, and tolerability of 1-gram ovules, administered as ultra - short 2-day regimen. J Chemother 2044; 16: 179-86.
  28. Gorlero F, Sartani A, Cordaro C.I et al. Fenticonazole tissue levels after the application of 3 different dosage forms of vaginal ovules. Int J Clin Pharmacol Ther Toxicol 1988; 26 (10): 479-81.
  29. Wiest W, Ruffmann R. Short - term treatment of vaginal candidiasis with fenticonazole ovules: a three - dose schedule comparative trial. J Int Med Res 1987; 15 (5): 319-25.
  30. Радзинский В.Е., Артымук Н.В., Берлев И.В. и др. Рандомизированное многоцентровое исследование эффективности применения 600 и 1200 мг препарата Ломексин в лечении кандидозного вульвовагинита у женщин репродуктивного возраста. Акушерство и гинекология. 2013; 2: 113-8.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).